MRI Assessment of Cervical Cancer for Adaptive Radiotherapy

• Published in: Strahlentherapie und Onkologie 2009-05, Vol.185 (5), p.282-287
• Main Authors: Dimopoulos, Johannes C. A., Schirl, Gertrude, Baldinger, Anja, Helbich, Thomas H., Pötter, Richard
• Format: Article
• Language: English
• Subjects: Adult; Aged; Brachytherapy - methods; Female; Humans; Magnetic Resonance Imaging - methods; Medicine; Medicine & Public Health; Middle Aged; Oncology; Original Article; Radiotherapy; Radiotherapy, Computer-Assisted - methods; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Uterine Cervical Neoplasms - diagnosis; Uterine Cervical Neoplasms - radiotherapy
• ISSN: 0179-7158; 1439-099X
• DOI: 10.1007/s00066-009-1918-7

Purpose: To assess the importance of the information obtained from MRI for adaptive cervix cancer radiotherapy. Patients and Methods: 49 patients with cervix cancer, treated by external-beam radiotherapy (EBRT) and MRI-assisted high-dose-rate brachytherapy ± concomitant cisplatin, underwent MRI at diagnosis and at the time of brachytherapy fractions. 190 MRI examinations were performed. Pretreatment scans were correlated with clinical examination (CE) findings. Measurements in 3-D of the tumor extension and also of the distance from the tumor to the pelvic side wall were performed using both MRI and CE. The tumor volume regression induced initially by EBRT and the subsequent regression after each brachytherapy fraction were assessed. Results: MRI and CE showed 92% agreement in overall parametrial staging and 73% agreement in terms of vaginal involvement. There was, however, disagreement in parametrial side (right/left) classification in 25% of the parametria examined. These were patients with unilateral displacement of the cervix and contralateral invasion of the parametrium. The mean tumor volume on the pretreatment MRI scan (GTVD) was 61 cm 3 . At the time of the four brachytherapy fractions the mean was 16 cm 3 , 10 cm 3 , 9 cm 3 , and 8 cm 3 , defined as the GTVBT plus the gray zones in the parametria. Conclusion: CE and MRI findings agree well in terms of overall staging. The clinical assessment of side-specific parametrial invasion improved when having access to the additional knowledge obtained from MRI. The greatest decrease in tumor volume occurs during EBRT, whereas tumor regression between the first and subsequent brachytherapy fractions is minor.